Author Index

Author Response to the Comment on “Time Trends in Cardiovascular Event Incidence in New‐Onset Type 2 Diabetes: A Population‐Based Cohort Study From Germany”
di: Theresia Sarabhai, et al.
Pubblicazione: (2025)

Does Metabolic Status Associate With IVF Outcomes in Women Within Similar Body Mass Index Category: Evidence From a Large Cohort Study
di: Lin Ding, et al.
Pubblicazione: (2025)

The Role of Prognostic Nutritional Index in UTI Susceptibility Among Female Type 2 Diabetic Patients
di: Chao-Yin Lu, et al.
Pubblicazione: (2025)

Endothelial Activation Stress Index predicts all‐cause and cardiovascular mortality in patients with diabetes: A nationwide study
di: Gaiying Dong, et al.
Pubblicazione: (2025)

Association Between the Waist–Triglyceride Index and Incident Type 2 Diabetes in the Elderly: A Retrospective Cohort Study
di: Qianqian Wang, et al.
Pubblicazione: (2025)

Author's Reply to Letter to Editor in response to the article “Rising mortality rates linked to type‐2 diabetes and obesity in the United States: An observational analysis from 1999 to 2022”
di: Mushood Ahmed, et al.
Pubblicazione: (2025)

Association of Geriatric Nutritional Risk Index With Cardiovascular and All‐Cause Mortality Among US Elderly Adults With Diabetic Nephropathy
di: Chun Sun, et al.
Pubblicazione: (2025)

Development and Validation of an Integrated Metabolism‐Obesity Index for Screening Renal Impairment in Patients With Newly Diagnosed Type 2 Diabetes Mellitus
di: Xiangying Zhu, et al.
Pubblicazione: (2026)

Association of the Fibrosis‐4 Index With Indices of Atherosclerosis in Patients With Type 2 Diabetes: An Exploratory Subanalysis of a Prospective Observational Cohort Study
di: Kenichi Tanaka, et al.
Pubblicazione: (2026)

Joint Effects of Physical Activity and Body Mass Index on Prevalent Diabetes in a Nationally Representative Sample of 1.9 Million US Adults
di: David Abernethy, et al.
Pubblicazione: (2025)

Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012–2017
di: Su Jin Jeong, et al.
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up
di: Wei You, et al.
Pubblicazione: (2026)

Commentary on the T1D Exchange Quality Improvement Collaborative Learning Session November 2025 Abstracts
di: Stephanie S. Crossen, et al.
Pubblicazione: (2026)

Identify Diagnostic Biomarkers Related to Taurine Metabolism in Diabetic Foot Ulcers Using Bulk RNA ‐seq and ScRNA‐seq Analysis
di: Mengrong He, et al.
Pubblicazione: (2026)

Multimorbidity between Type 2 Diabetes and Depressive Symptoms in Mexico: Prevalence and Associated Factors From the Nationally Representative ENSANUT 2022 Survey
di: Ankita Adhikari, et al.
Pubblicazione: (2026)

Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross‐Sectional Study in China
di: Minghan Zhang, et al.
Pubblicazione: (2026)

Local Versus Systemic Antibiotics for Diabetic Foot Infection—A Systematic Review and Meta‐Analysis
di: Anas Khan, et al.
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

Effects of FTO Gene rs9939609 and rs17817449 Polymorphisms on Insulin Resistance in Turkish Children With Obesity
di: Merve Köksal, et al.
Pubblicazione: (2026)

The Role of Negative Pressure Therapy in Diabetic Foot Ulcer: A Meta‐Analysis
di: Hai Du, et al.
Pubblicazione: (2026)

Pain Modulation and Central Sensitization in Painful Diabetic Peripheral Neuropathy: Updated Narrative Review and Future Directions
di: Di Ye, et al.
Pubblicazione: (2026)

The Interaction Between Mitophagy Dysregulation and the Diabetic Bladder Microenvironment
di: Shi Li, et al.
Pubblicazione: (2026)

Beyond GLP ‐1
di: Zachary Bloomgarden
Pubblicazione: (2026)

Establishing the China‐ SCO Cooperation Center for Metabolic Diseases to Build a Prevention and Control System for Metabolic Disorders, Advancing the Global Community of Shared Future
di: Guang Ning
Pubblicazione: (2026)

Is There Any Difference in Preferences Between Patients and Physicians? Evidence From Anti‐Hyperglycemic Medications Choices for Type 2 Diabetes
di: Yuliang Xiang, et al.
Pubblicazione: (2026)

Impact of Cardiometabolic Risk Markers on the Incidence and Progression Arterial Stiffness in Patients With Prediabetes
di: Qi Sun, et al.
Pubblicazione: (2026)

Comprehensive Management of Diabetic Foot Ulcers: Current Evidence and Practice
di: Ji Min Kim, et al.
Pubblicazione: (2026)

Algorithm‐Based Common Microcirculatory Framework for Monitoring and Visualizing the Integrated Pancreatic Microcirculation in Type 2 Diabetes Mellitus Mice
di: Yuan Li, et al.
Pubblicazione: (2026)

Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities
di: Zachary T. Bloomgarden
Pubblicazione: (2026)

Insights Into Macrophage Polarization and M1 / M2 Balance in Diabetic Foot Ulcers
di: Jing Zhang, et al.
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

The Debate on the Dietary Guidelines for Americans (2025–2030) and Implications for China's Nutritional Policy
di: Junshi Chen
Pubblicazione: (2026)

Neuroinflammation‐Associated Optic Structural–Functional Degeneration in Early Diabetic Optic Neuropathy
di: Jingyuan Zhu, et al.
Pubblicazione: (2026)

Updates in Type 1 Diabetes ( T1D ): What Recent Findings Might Mean for Treatment and Prevention Strategies
di: Zachary Bloomgarden
Pubblicazione: (2026)

Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes
di: Ruihan Li, et al.
Pubblicazione: (2026)